About Jon Brilliant
Form D filings for CorriXR Therapeutics in 2024 list Jon Brilliant as executive officer.
Jon Brilliant first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jon Brilliant in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jon Brilliant works with at each company, as listed on that company's latest Form D.
CorriXR Therapeutics, Inc. · Form D/A, Jan 29, 2024
JC
Jeffrey Carper
Director
DM
Deborah Moorad
Chief Executive Officer and director
JN
Janice Nevin
Director
SV
Stella Vnook
Director
EK
Eric Kmiec
Executive officer and director